MetLife Investment Management’s Stereotaxis STXS Stock Holding History

MetLife Investment Management’s Portfolio STXS Stock Details STXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,948	Closed	-$106K	–	2870
2025 Q3	$106K	Sell	33,948 -1,847	-5%	-$4.78K	﹤0.01%	2627
2025 Q2	$75.9K	Buy	+35,795	New	+$72.7K	﹤0.01%	2654
2022 Q1	–	Sell	-19,595	Closed	-$121K	–	2769
2021 Q4	$121K	Buy	19,595 +14,312	+271%	+$85.5K	﹤0.01%	2333
2021 Q3	$28.4K	Sell	5,283 -14,457	-73%	-$109K	﹤0.01%	2555
2021 Q2	$190K	Buy	+19,740	New	+$156K	﹤0.01%	2198
2020 Q3	–	Sell	-22,778	Closed	-$102K	–	2332
2020 Q2	$102K	Buy	+22,778	New	+$92.2K	﹤0.01%	2249

Other funds holding STXS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MetLife Investment Management's STXS Position: Q4 2025 in Review

MetLife Investment Management sold out of Stereotaxis (STXS) in Q4 2025, closing a stake of 33,948 shares — an estimated $106K sold.

MetLife Investment Management first reported a position in STXS in Q2 2020 and held it in 6 quarters. The position peaked at $190K in Q2 2021. 105 funds tracked by Wall St. Rank hold STXS as of Q4 2025.

MetLife Investment Management reported no remaining Stereotaxis position as of Q4 2025 after selling out during the quarter.
MetLife Investment Management sold 33,948 Stereotaxis shares in Q4 2025, an estimated $106K.
MetLife Investment Management first reported a position in Stereotaxis in Q2 2020 and held it in 6 quarters.
MetLife Investment Management's Stereotaxis position peaked at $190K in Q2 2021.
105 funds tracked by Wall St. Rank held Stereotaxis as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.